82 related articles for article (PubMed ID: 10637)
1. Reactivity of fibrinogen crosslinking sites in the absence of thrombin.
Seelich T; Furlan M; Beck EA
Thromb Haemost; 1976 Jun; 35(3):620-7. PubMed ID: 10637
[TBL] [Abstract][Full Text] [Related]
2. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
Siebenlist KR; Meh DA; Mosesson MW
Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen assembly and crosslinking on a fibrin fragment E template.
Mosesson MW; Siebenlist KR; Hernandez I; Wall JS; Hainfeld JF
Thromb Haemost; 2002 Apr; 87(4):651-8. PubMed ID: 12008948
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
[TBL] [Abstract][Full Text] [Related]
5. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
Furlan M; Seelich T; Beck EA
Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
[TBL] [Abstract][Full Text] [Related]
6. A thiocholine ester of cinnamic acid inhibits crosslinking of fibrin without specific binding to donor lysines.
Perret BA; Seelich T; Furlan M; Beck EA
Thromb Haemost; 1979 Jun; 41(4):695-701. PubMed ID: 483243
[TBL] [Abstract][Full Text] [Related]
7. Soluble fibrin complexes: separation as a function of pH and characterization.
Benabid Y; Concord E; Suscillon M
Thromb Haemost; 1977 Feb; 37(1):144-53. PubMed ID: 14416
[TBL] [Abstract][Full Text] [Related]
8. Early alpha chain crosslinking in human fibrin preparations.
Sobel JH; Thibodeau CA; Canfield RE
Thromb Haemost; 1988 Oct; 60(2):153-9. PubMed ID: 3217916
[TBL] [Abstract][Full Text] [Related]
9. Crosslinking kinetics of the human transglutaminase, factor XIII[A2], acting on fibrin gels and gamma-chain peptides.
Lewis KB; Teller DC; Fry J; Lasser GW; Bishop PD
Biochemistry; 1997 Feb; 36(5):995-1002. PubMed ID: 9033388
[TBL] [Abstract][Full Text] [Related]
10. Plasma and platelet fibrinogen differ in gamma chain content.
Francis CW; Nachman RL; Marder VJ
Thromb Haemost; 1984 Feb; 51(1):84-8. PubMed ID: 6719392
[TBL] [Abstract][Full Text] [Related]
11. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
Brown CH; Crowe MF
J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic evaluation of factor XIIIa*-like enzyme activity in equine plasma as a potential therapeutic avenue for the inhibition of fibrinous tissue.
Coyne CP; Smith JE; DeBowes RM
Am J Vet Res; 1992 May; 53(5):695-705. PubMed ID: 1355954
[TBL] [Abstract][Full Text] [Related]
13. Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.
Hevessy Z; Haramura G; Boda Z; Udvardy M; Muszbek L
Thromb Haemost; 1996 Jan; 75(1):161-7. PubMed ID: 8713796
[TBL] [Abstract][Full Text] [Related]
14. Regulation of plasma factor XIII binding to fibrin in vitro.
Greenberg CS; Dobson JV; Miraglia CC
Blood; 1985 Nov; 66(5):1028-34. PubMed ID: 2413926
[TBL] [Abstract][Full Text] [Related]
15. Crosslinking of soluble fibrin and fibrinogen.
Selmayr E; Mahn I; Müller-Berghaus G
Thromb Res; 1985 Aug; 39(4):467-74. PubMed ID: 2864751
[TBL] [Abstract][Full Text] [Related]
16. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
Colick JA; Fisher LM
Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
[No Abstract] [Full Text] [Related]
17. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
Pizzo SV; Schwartz ML; Hill RL; McKee PA
J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
[TBL] [Abstract][Full Text] [Related]
18. New method to prepare autologous fibrin glue on demand.
Alston SM; Solen KA; Broderick AH; Sukavaneshvar S; Mohammad SF
Transl Res; 2007 Apr; 149(4):187-95. PubMed ID: 17383592
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.
Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S
Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly.
Mosesson MW
Blood Coagul Fibrinolysis; 1997 Jul; 8(5):257-67. PubMed ID: 9282789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
